Liquidia Corporation Insider Trading

LQDA

Last 12 months

Insiders bought 318K and sold $231M on the open market.

33% of the selling was scheduled in advance under 10b5-1 plans. Director Stephen M Bloch sold $26.6M on Jun 11, 24% of their stake, outside a plan.

Net open-market

−$230M

1 buy · 97 sales

Under a 10b5-1 plan

33%

of the value sold

Insiders who bought / sold

1 / 15

executives and directors

Last open-market buy

May 2026

May 19, 2026

Get an email when LQDA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 26	Dana Boyle Chief Accounting Officer	Sold10b5-1 plan	1,581	$43.19	68K	1.0%	Form 4
Oct 26	Jason Adair Chief Business Officer	Sold10b5-1 plan	688	$43.19	30K	0.4%	Form 4
Oct 12	Russell Schundler General Counsel	Sold10b5-1 plan	13,692	$28.48	390K	2.2%	Form 4
Oct 12	Rajeev Saggar Chief Medical Officer	Sold10b5-1 plan	9,218	$28.48	263K	6.1%	Form 4
Oct 12	Scott Moomaw Chief Commercial Officer	Sold10b5-1 plan	8,863	$28.48	252K	4.7%	Form 4
Oct 12	Sarah Krepp Chief Human Resource Officer	Sold10b5-1 plan	5,245	$28.48	149K	4.4%	Form 4
Oct 12	Sanjeev Khindri Chief Development Officer	Sold10b5-1 plan	1,101	$28.48	31K	1.7%	Form 4
Oct 12	Michael Kaseta CFO and COO	Sold10b5-1 plan	18,938	$28.48	539K	5.3%	Form 4
Oct 12	Roger Jeffs Chief Executive Officer	Sold10b5-1 plan	32,744	$28.48	933K	2.7%	Form 4
Oct 12	Dana Boyle Chief Accounting Officer	Sold10b5-1 plan	5,892	$28.48	168K	3.4%	Form 4
Oct 12	Jason Adair Chief Business Officer	Sold10b5-1 plan	7,301	$28.48	208K	3.9%	Form 4
Oct 5	Stephen M Bloch Director	SoldNo plan	235,477	$27.13	$6.39M	69%	Form 4
Sep 11 – 14	Raman Singh Director	SoldNo plan 2 parts	17,492	$67.43 average	$1.18M	28%	Form 4
Sep 1	Sarah Krepp Chief Human Resource Officer	Sold10b5-1 plan	274	$67.76	19K	0.2%	Form 4
Aug 21	Jason Adair Chief Business Officer	Sold10b5-1 plan 2 parts	73,631	$69.09 average	$5.09M	30%	Form 4
Aug 19 – 20	Katherine Rielly-Gauvin Director	Sold10b5-1 plan 2 parts	55,182	$74.07 average	$4.09M	55%	Form 4
Aug 17 – 19	Rajeev Saggar Chief Medical Officer	SoldNo plan 2 parts	79,534	$75.09 average	$5.97M	36%	Form 4
Jul 27	Dana Boyle Chief Accounting Officer	Sold10b5-1 plan	1,600	$87.53	140K	0.9%	Form 4
Jul 27	Jason Adair Chief Business Officer	Sold10b5-1 plan	688	$87.53	60K	0.3%	Form 4
Jul 22 – 23	Stephen M Bloch Director	SoldNo plan 5 parts	200,000	$88.93 average	$17.8M	26%	Form 4
Jul 20 – 21	Stephen M Bloch Director	SoldNo plan 3 parts	78,596	$79.97 average	$6.28M	9.2%	Form 4
Jul 13	Sarah Krepp Chief Human Resource Officer	Sold10b5-1 plan 2 parts	7,864	$71.51 average	562K	6.3%	Form 4
Jul 13	Sanjeev Khindri Chief Development Officer	Sold10b5-1 plan 2 parts	1,185	$71.51 average	85K	1.8%	Form 4
Jul 13	Michael Kaseta CFO and COO	Sold10b5-1 plan 2 parts	20,430	$71.51 average	$1.46M	5.6%	Form 4
Jul 13	Roger Jeffs Chief Executive Officer	Sold10b5-1 plan 2 parts	35,249	$71.51 average	$2.52M	2.9%	Form 4
Jul 13	Jason Adair Chief Business Officer	Sold10b5-1 plan 2 parts	7,863	$71.51 average	562K	3.5%	Form 4
Jul 13	Russell Schundler General Counsel	Sold10b5-1 plan 2 parts	14,738	$71.51 average	$1.05M	2.3%	Form 4
Jul 13	Rajeev Saggar Chief Medical Officer	Sold10b5-1 plan 2 parts	9,926	$71.51 average	710K	5.5%	Form 4
Jul 13	Scott Moomaw Chief Commercial Officer	Sold10b5-1 plan 2 parts	9,539	$71.51 average	682K	5.0%	Form 4
Jul 13	Dana Boyle Chief Accounting Officer	Sold10b5-1 plan 2 parts	9,002	$71.51 average	644K	5.0%	Form 4
Jul 6 – 7	Stephen M Bloch Director	SoldNo plan 3 parts	75,000	$80.68 average	$6.05M	8.1%	Form 4
Jul 1	Stephen M Bloch Director	SoldNo plan 2 parts	25,000	$79.47 average	$1.99M	2.6%	Form 4
Jun 22	Stephen M Bloch Director	SoldNo plan 2 parts	100,000	$75.74 average	$7.57M	9.5%	Form 4
Jun 12 – 15	Stephen M Bloch Director	SoldNo plan 4 parts	196,111	$71.45 average	$14M	16%	Form 4
Jun 11	Sarah Krepp Chief Human Resource Officer	Sold10b5-1 plan 2 parts	24,880	$70.28 average	$1.75M	17%	Form 4
Jun 10 – 11	Stephen M Bloch Director	SoldNo plan 10 parts	388,223	$68.61 average	$26.6M	24%	Form 4
Jun 8 – 9	Stephen M Bloch Director	SoldNo plan 5 parts	220,835	$64.63 average	$14.3M	12%	Form 4
Jun 8	Sanjeev Khindri Chief Development Officer	Sold10b5-1 plan	4,134	$65.46	271K	5.8%	Form 4
Jun 4 – 5	Stephen M Bloch Director	SoldNo plan 4 parts	84,800	$64.95 average	$5.51M	4.4%	Form 4
Jun 4	Paul B Manning Director	SoldNo plan 5 parts	200,000	$63.91 average	$12.8M	4.8%	Form 4

Oct 2610b5-1 plan
Dana Boyle
Chief Accounting Officer · sold 1,581 at $43.19
68K
1.0% of stake
Oct 2610b5-1 plan
Jason Adair
Chief Business Officer · sold 688 at $43.19
30K
0.4% of stake
Oct 1210b5-1 plan
Russell Schundler
General Counsel · sold 13,692 at $28.48
390K
2.2% of stake
Oct 1210b5-1 plan
Rajeev Saggar
Chief Medical Officer · sold 9,218 at $28.48
263K
6.1% of stake
Oct 1210b5-1 plan
Scott Moomaw
Chief Commercial Officer · sold 8,863 at $28.48
252K
4.7% of stake
Oct 1210b5-1 plan
Sarah Krepp
Chief Human Resource Officer · sold 5,245 at $28.48
149K
4.4% of stake
Oct 1210b5-1 plan
Sanjeev Khindri
Chief Development Officer · sold 1,101 at $28.48
31K
1.7% of stake
Oct 1210b5-1 plan
Michael Kaseta
CFO and COO · sold 18,938 at $28.48
539K
5.3% of stake
Oct 1210b5-1 plan
Roger Jeffs
Chief Executive Officer · sold 32,744 at $28.48
933K
2.7% of stake
Oct 1210b5-1 plan
Dana Boyle
Chief Accounting Officer · sold 5,892 at $28.48
168K
3.4% of stake
Oct 1210b5-1 plan
Jason Adair
Chief Business Officer · sold 7,301 at $28.48
208K
3.9% of stake
Oct 5No plan
Stephen M Bloch
Director · sold 235,477 at $27.13
$6.39M
69% of stake
Sep 11 – 14No plan
Raman Singh
Director · sold 17,492 at avg $67.43
$1.18M
28% of stake
Sep 110b5-1 plan
Sarah Krepp
Chief Human Resource Officer · sold 274 at $67.76
19K
0.2% of stake
Aug 2110b5-1 plan
Jason Adair
Chief Business Officer · sold 73,631 at avg $69.09
$5.09M
30% of stake
Aug 19 – 2010b5-1 plan
Katherine Rielly-Gauvin
Director · sold 55,182 at avg $74.07
$4.09M
55% of stake
Aug 17 – 19No plan
Rajeev Saggar
Chief Medical Officer · sold 79,534 at avg $75.09
$5.97M
36% of stake
Jul 2710b5-1 plan
Dana Boyle
Chief Accounting Officer · sold 1,600 at $87.53
140K
0.9% of stake
Jul 2710b5-1 plan
Jason Adair
Chief Business Officer · sold 688 at $87.53
60K
0.3% of stake
Jul 22 – 23No plan
Stephen M Bloch
Director · sold 200,000 at avg $88.93
$17.8M
26% of stake
Jul 20 – 21No plan
Stephen M Bloch
Director · sold 78,596 at avg $79.97
$6.28M
9.2% of stake
Jul 1310b5-1 plan
Sarah Krepp
Chief Human Resource Officer · sold 7,864 at avg $71.51
562K
6.3% of stake
Jul 1310b5-1 plan
Sanjeev Khindri
Chief Development Officer · sold 1,185 at avg $71.51
85K
1.8% of stake
Jul 1310b5-1 plan
Michael Kaseta
CFO and COO · sold 20,430 at avg $71.51
$1.46M
5.6% of stake
Jul 1310b5-1 plan
Roger Jeffs
Chief Executive Officer · sold 35,249 at avg $71.51
$2.52M
2.9% of stake
Jul 1310b5-1 plan
Jason Adair
Chief Business Officer · sold 7,863 at avg $71.51
562K
3.5% of stake
Jul 1310b5-1 plan
Russell Schundler
General Counsel · sold 14,738 at avg $71.51
$1.05M
2.3% of stake
Jul 1310b5-1 plan
Rajeev Saggar
Chief Medical Officer · sold 9,926 at avg $71.51
710K
5.5% of stake
Jul 1310b5-1 plan
Scott Moomaw
Chief Commercial Officer · sold 9,539 at avg $71.51
682K
5.0% of stake
Jul 1310b5-1 plan
Dana Boyle
Chief Accounting Officer · sold 9,002 at avg $71.51
644K
5.0% of stake
Jul 6 – 7No plan
Stephen M Bloch
Director · sold 75,000 at avg $80.68
$6.05M
8.1% of stake
Jul 1No plan
Stephen M Bloch
Director · sold 25,000 at avg $79.47
$1.99M
2.6% of stake
Jun 22No plan
Stephen M Bloch
Director · sold 100,000 at avg $75.74
$7.57M
9.5% of stake
Jun 12 – 15No plan
Stephen M Bloch
Director · sold 196,111 at avg $71.45
$14M
16% of stake
Jun 1110b5-1 plan
Sarah Krepp
Chief Human Resource Officer · sold 24,880 at avg $70.28
$1.75M
17% of stake
Jun 10 – 11No plan
Stephen M Bloch
Director · sold 388,223 at avg $68.61
$26.6M
24% of stake
Jun 8 – 9No plan
Stephen M Bloch
Director · sold 220,835 at avg $64.63
$14.3M
12% of stake
Jun 810b5-1 plan
Sanjeev Khindri
Chief Development Officer · sold 4,134 at $65.46
271K
5.8% of stake
Jun 4 – 5No plan
Stephen M Bloch
Director · sold 84,800 at avg $64.95
$5.51M
4.4% of stake
Jun 4No plan
Paul B Manning
Director · sold 200,000 at avg $63.91
$12.8M
4.8% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LQDA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with LQDA

CompareIntrinsic value

ARDXArdelyx Inc.

$3.27+7.92%40

ZLABZai Lab Ltd

$22.80+3.83%40

SVASernova Biotherapeutics Inc

No recent price0

ORGOOrganogenesis Holdings Inc.

$0.87+4.19%50

INVAInnoviva Inc.

$21.26+1.58%56

ARQTArcutis Biotherapeutics Inc.

$34.05+6.41%65

ESPREsperion Therapeutics Inc.

No recent price50

NATRNature's Sunshine Products Inc.

$12.84+6.38%70

Held by ETFs

LQDA is in 79 US ETFs. The largest of them, with LQDA's weight in each:

Spot a number that looks wrong? Check it in LQDA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LQDA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.